// App-Quantinova.ai

SAT0351 : CHEMOKINE PATHWAYS ARE ENRICHED IN PSORIATIC ARTHRITIS (PSA) SKIN LESIONS WITH INCREASED EXPRESSION OF ATYPICAL CHEMOKINE RECEPTOR 2 (ACKR2)

Researchers

Presenter

  • H. Johnsson

Principal Investigators

  • J. Cole

  • G. Wilson

  • M. Pingen

  • F. Mcmonagle

  • S. Holmes

  • I. Mcinnes

  • S. Siebert

  • G. Graham

Medical Centers

  • University of Glasgow, Institute of Infection Immunity and Inflammation, Glasgow, United Kingdom

  • Alan Lyell Centre for Dermatology, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • Cluster of differentiation 45

  • Prostate specific antigen

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A